Created at	Source	Raw Value	Validated value
Aug. 29, 2024, 8 a.m.	usa	Immunogenicity of Messenger Ribonucleic Acid (mRNA) Titers - 1273 Administered in 2 Doses in the Initial Phase;Number of Participants Who Had Vital Signs Performed Prior to Vaccine;Number of Participants With Grades 1-5 Solicited (Expected) and/or Unsolicited (Unexpected) Adverse Events (AE's): Booster Phase;Number of Participants With Grades 1-5 Solicited (Expected) and/or Unsolicited (Unexpected) Adverse Events (AE's): Initial Phase;Number of Participants With Reactogenicity of Messenger Ribonucleic Acid (mRNA) -1273 of a Booster Vaccination: Booster Phase;Number of Participants With Reactogenicity of Messenger Ribonucleic Acid (mRNA)-1273 Vaccine: Initial Phase	Immunogenicity of Messenger Ribonucleic Acid (mRNA) Titers - 1273 Administered in 2 Doses in the Initial Phase;Number of Participants Who Had Vital Signs Performed Prior to Vaccine;Number of Participants With Grades 1-5 Solicited (Expected) and/or Unsolicited (Unexpected) Adverse Events (AE's): Booster Phase;Number of Participants With Grades 1-5 Solicited (Expected) and/or Unsolicited (Unexpected) Adverse Events (AE's): Initial Phase;Number of Participants With Reactogenicity of Messenger Ribonucleic Acid (mRNA) -1273 of a Booster Vaccination: Booster Phase;Number of Participants With Reactogenicity of Messenger Ribonucleic Acid (mRNA)-1273 Vaccine: Initial Phase
June 10, 2022, 4:30 p.m.	usa	Assess immunogenicity of m-RNA 1273 administered in 2 doses;Safety and reactogenicity of MRNA-1273 of a booster vaccination;Safety and reactogenicity of MRNA-1273 vaccine	Assess immunogenicity of m-RNA 1273 administered in 2 doses;Safety and reactogenicity of MRNA-1273 of a booster vaccination;Safety and reactogenicity of MRNA-1273 vaccine
June 9, 2022, 4 p.m.	usa	None
Nov. 17, 2021, 7 p.m.	usa	Assess immunogenicity of m-RNA 1273 administered in 2 doses;Safety and reactogenicity of MRNA-1273 of a booster vaccination;Safety and reactogenicity of MRNA-1273 vaccine	Assess immunogenicity of m-RNA 1273 administered in 2 doses;Safety and reactogenicity of MRNA-1273 of a booster vaccination;Safety and reactogenicity of MRNA-1273 vaccine
April 22, 2021, 12:31 a.m.	usa	Assess immunogenicity of m-RNA 1273 administered in 2 doses;Safety and reactogenicity of MRNA-1273 vaccine	Assess immunogenicity of m-RNA 1273 administered in 2 doses;Safety and reactogenicity of MRNA-1273 vaccine